Research on the Construction and Application of an Intervention Program for Sleep Disorders in Stable COPD Patients Based on Symptom Management Theory

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2600127365

Enrollment

Unknown

Registered

2026-06-30

Start date

2026-08-01

Completion date

Unknown

Last updated

2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD

Interventions

Intervention group:Routine nursing care plus a sleep disturbance intervention program for stable COPD patients based on symptom management theory (including room environment optimization, psychologica

Control group:Receive routine nursing care and sleep health education (fixed bedtime and wake-up time, daily moderate exercise, avoiding naps, reducing fluid intake before bedtime, avoiding nocturnal

Expert Group:None

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Expert inclusion criteria: 1. Engaged in work related to respiratory medicine, sleep medicine, rehabilitation therapy, clinical nursing, psychology, or other relevant fields. 2. Possess an intermediate or above professional technical title. 3. Familiar with knowledge in the field of COPD or sleep disorders, and have at least 10 years of clinical work experience. 4. Highly motivated and willing to actively participate in this study throughout the entire process. Part 2: Application of a sleep disorder intervention program for stable COPD patients based on symptom management theory 1. Meet the diagnostic criteria of the "Guidelines for the Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease" and be in a stable stage. 2. Age = 18 years. 3. Poor sleep quality with a PSQI score > 7. 4. Clear consciousness, normal cognitive function, and ability to communicate effectively. 5. Voluntary participation in this study.

Exclusion criteria

Exclusion criteria: 1. Individuals with severe cardiovascular and cerebrovascular diseases, malignant tumors, chronic pain disorders or sleep apnea-hypopnea syndrome; 2. Patients with a history of mental illness or severe anxiety and depression; 3. Those who have been taking sedative and sleep-promoting drugs for a long time.

Design outcomes

Primary

Measure	Time frame
Pittsburgh Sleep Quality Index;Pulmonary function;6-Minute Walk Test;Hamilton Anxiety Scale;	—

Secondary

Measure	Time frame
Hamilton Depression Scale;COPD Assessment Test;	—

Countries

China

Contacts

Public ContactWu Miyao

Hunan Provincial People's Hospital

2431307663@qq.com+86 731 83929550

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026